Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Treatment of Comorbid Tobacco Addiction in Substance Use and Psychiatric Disorders

Treatment of Comorbid Tobacco Addiction in Substance Use and Psychiatric Disorders Tobacco addiction is the leading cost of preventable morbidity and mortality in the western world. Substance use (SUD) and psychiatric (PD) disorders are important contributors to the high rates of tobacco addiction, and smokers with these comorbidities demonstrate lower rates of quitting compared with smokers in the general population. This article will review reasons for the high rates of co-occurring SUDs and PDs in people with tobacco addiction, and propose approaches to their assessment and treatment based on the recent literature. The recognition of SUDs and PDs in tobacco smokers is an important goal for all clinicians treating tobacco addiction, and an approach that integrates these treatments leads to optimal treatment outcomes for this important subset of tobacco smokers. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Current Addiction Reports Springer Journals

Treatment of Comorbid Tobacco Addiction in Substance Use and Psychiatric Disorders

Loading next page...
 
/lp/springer-journals/treatment-of-comorbid-tobacco-addiction-in-substance-use-and-NbCyLO0jAa
Publisher
Springer Journals
Copyright
Copyright © 2013 by Springer International Publishing AG
Subject
Medicine & Public Health; Psychiatry; Neurology
eISSN
2196-2952
DOI
10.1007/s40429-013-0001-8
Publisher site
See Article on Publisher Site

Abstract

Tobacco addiction is the leading cost of preventable morbidity and mortality in the western world. Substance use (SUD) and psychiatric (PD) disorders are important contributors to the high rates of tobacco addiction, and smokers with these comorbidities demonstrate lower rates of quitting compared with smokers in the general population. This article will review reasons for the high rates of co-occurring SUDs and PDs in people with tobacco addiction, and propose approaches to their assessment and treatment based on the recent literature. The recognition of SUDs and PDs in tobacco smokers is an important goal for all clinicians treating tobacco addiction, and an approach that integrates these treatments leads to optimal treatment outcomes for this important subset of tobacco smokers.

Journal

Current Addiction ReportsSpringer Journals

Published: Nov 20, 2013

There are no references for this article.